Nowtransit INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NOTR
Nowtransit INCBioScience Health Innovations reported 2025 revenue up 208% to $5.69M and net income of $0.64M, detailed capital-raising and uplist plans, and disclosed material internal control weaknesses.
NOTR
Nowtransit INCNowtransit Inc. reports a profitable year end, driven by increased revenue following a reverse merger and a shift to clinically-tested health products.
NOTR
Nowtransit INC10-K: Nowtransit Inc. Reports Full Year 2023 Results, Highlights Reverse Merger and Growth Initiatives
Nowtransit Inc.'s 2023 annual report details a reverse merger, increased revenue, and a net loss, alongside plans for future growth in the health and wellness market.